✦ LIBER ✦

The efficacy and tolerability of add-on acarbose therapy in type 2 diabetes mellitus patients inadequately controlled by glibenclamid alone

✍ Scribed by I. Kinalska; V. Novikov; G. Tamas; S. Czekalski; M. Balabolkin; Z. Szybinski; J. Borawski; M. Stra̧czkowski

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and tolerability of acarbose in

✍ Boniface J. Lin; Huey-Peir Wu; H.S. Huang; Jyuhn Huarng; A. Sison; Dato Khalid b 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Efficacy and safety of acarbose add-on t

✍ S Halimi; M.A Le Berre; V Grangé 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Evaluation of the efficacy and tolerabil

✍ Sheng-Hwu Hsieh; Kuang-Chung Shih; Chien-Wen Chou; Chih-Hsun Chu 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 215 KB

Efficacy and tolerability of vildaglipti

✍ C. Pan; X. Xing; P. Han; S. Zheng; J. Ma; J. Liu; X. Lv; J. Lu; G. Bader; on beh 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 683 KB

Efficacy and safety of rosiglitazone com

✍ Julio Rosenstock; MargaretM. Kreider; Lisa Menci; Mark Heise; MartinI. Freed 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Post-meal β-cell function predicts the e

✍ Chen, Po-Hsun; Tsai, Yi-Ting; Wang, Jun-Sing; Lin, Shi-Dou; Lee, Wen-Jane; Su, S 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 234 KB